Ophthotech sponsors gene therapy research for retinal diseases – Healio
|
Ophthotech sponsors gene therapy research for retinal diseases
Healio Ophthotech has begun a gene therapy research collaboration that will use novel gene therapy technology to discover and develop ocular disease treatments, according to a press release. The company has entered into sponsored research agreements with the … Ophthotech's (OPHT) CEO Glenn Sblendorio on Q4 2017 Results – Earnings Call Transcript |
